The firm issued an outperform rating and a $56.00 target price on the stock. Other equities analysts also recently issued reports about the stock.
Category: Raymond Ltd
Bioverativ Inc (Bivv) Receives New Coverage from Analysts at Raymond James Financial, Inc.
The brokerage issued a strong-buy rating and a $59.00 target price on the stock. Other equities research analysts have also recently issued research reports about the stock.
Universal American Corp. (UAM) Lowered to Hold at Zacks Investment Research
According to Zacks, “Universal American Corp. offers a range of health insurance and managed care products and services, and is dedicated to working collaboratively with doctors, pharmacists and other caring professionals to improve the health and well-being of its members. It offers these services primarily to the senior population.